Intralink Spine???s R??juve Treatment Nears Completion Of Safety Study And Begins Multi-Site Pivotal Study Post author:Sam Post published:January 30, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Medtronic Receives CE Mark For Its Next Generation Cardiac Resynchronization Therapy-Pacemakers February 23, 2017 Biohaven Eyes $100 Million IPO to Bankroll Trials of Shelved AstraZeneca PLC, Bristol-Myers Squibb Drugs April 9, 2017 Germany's Fresenius Kabi AG Slams Down $4.3 Billion for Akorn in U.S. Expansion April 24, 2017
Medtronic Receives CE Mark For Its Next Generation Cardiac Resynchronization Therapy-Pacemakers February 23, 2017
Biohaven Eyes $100 Million IPO to Bankroll Trials of Shelved AstraZeneca PLC, Bristol-Myers Squibb Drugs April 9, 2017